Cocrystal Pharma COCP
NASDAQ COCP
$0.96 +0.02 (+1.81%)
As of: Oct 21, 2026 · 3:20 PM EDT

Cocrystal Pharma (COCP) Debt Ratio (2010 - 2013)

Updated

Cocrystal Pharma's (COCP) Debt Ratio stood at 0.69 in Q2 2013, up 34.2% from 0.51 a year earlier but down 5.7% from the prior quarter.

Analysis

Cocrystal Pharma (COCP) Debt Ratio (2010 - 2013) Analysis & Trends

For FY2012, Cocrystal Pharma's Debt Ratio came in at 0.65, down 7.8% from FY2011.

  • Across earlier years, Debt Ratio came in at 0.71 in FY2011 (-8.3%) and 0.77 in FY2010.
  • Quarterly Debt Ratio has ranged from 0.51 in Q2 2012 to 0.77 in Q4 2010 over the past five years.
  • On a year-over-year basis, Debt Ratio rose in two of the last six quarters, with growth averaging 8.1%.
  • Per Business Quant, the preceding three quarters came in at 0.73 (Q1 2013), 0.65 (Q4 2012) and 0.55 (Q3 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Cocrystal Pharma 13.24 Mn -8.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 0.69
Mar 31, 2013 0.73
Dec 31, 2012 0.65
Sep 30, 2012 0.55
Jun 30, 2012 0.51
Mar 31, 2012 0.54
Dec 31, 2011 1.15
Sep 30, 2011 0.57
Jun 30, 2011 0.51
Dec 31, 2010 0.77
API Access

Cocrystal Pharma Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=COCP&period=max&api_key=YOUR_API_KEY